Wecompared the usefulness of a polymerase chain reaction (PCR) assay for the early diagnosis of invasive pulmonary aspergillosis with the serodiagnosis of sufficient concentrations of galactomannan using the same serum samples. A patient was treated with prednisolone for the managementof hepatitis. Computedtomography (CT) scan of the chest showed the nodular shadow with a cavity containing a clear fungus ball. DNA ofAspergillus spp. from a serum sample was detected and using the same serum sample, both latex agglutination and sandwich enzyme-linked immunosorbent assay (ELISA) of galactomannan were negative. PCRassay provides an early diagnosis of invasive pulmonary aspergillosis compared with ELISA of galactomannan.
Introduction
Invasive aspergillosis has a poor prognosis in immunocompromized patients. A reliable method, including a sensitive serodiagnostic test, for the early diagnosis of aspergillosis is not yet available. The latex agglutination test for the detection of circulating galactomannan ofAspergillus spp. is widely used in clinical laboratories for the diagnosis of invasive aspergillosis; however, the sensitivity of this assay is low (1) . In this regard, a polymerase chain reaction (PCR) assay provides a highly sensitive diagnosis of a variety of infectious diseases. The detection ofAspergillus DNAin bronchoalveolar lavage fluid samples of patients with invasive pulmonary aspergillosis is useful, but the bronchofiberscopic technique is impractical for routine use and could be hazardous in the immunocompromizedpatient (2) . Detection of the Aspergillus DNAby PCRassay using serum samples for the diagnosis of invasive pulmonary aspergillosis has been reported (3) . In the present case, we evaluated the usefulness of PCRassay for the early diagnosis of pulmonary aspergillosis and compared these results with serodiagnosis by detection of galactomannan.
Case Report A45-year-old man was admitted on June 7, 1997 to Nagasaki University Hospital for management of type B hepatitis. There were no abnormal shadows on radiological examination of the chest on admission. Hepatitis was treated with oral prednisolone (40 mg/day). A nodular shadow appeared in the lower lobe of the right lung in the chest X-ray on July 15, 1997 ( Fig.  1) . On laboratory data, leukocyte count was 8,600/|Lil and Creactive protein (CRP) was 0.84 mg/dl. The shadow was suspected to be a lung abscess on the finding of chest X-ray ( Fig.  2 ) and the patient was treated with antibiotics consisting of a course of 2 g/day piperacillin for 7 days followed by 1 g/day meropenemfor 7 days. This was followed by a change in the radiological appearance of the nodular shadowwith a cavity containing a clear fungus ball (Fig. 3) . DNAofAspergillus spp. from a serum sample was detected by PCRon July 28, 1997. Using the same serum sample, both latex agglutination test (Pastorex Aspergillus, Sanofi Diagnostics Pasteur, France) and sandwich enzyme-linked immunosorbent assay (ELISA) test (Platelia Aspergillus, Sanofi Diagnostics Pasteur, France)
for the detection of circulating galactomannanwere negative.
To confirm the PCRresults, the patient was examined bronchoscopically on July 30, 1997. Aspergillusfumigatus was isolated from bronchoalveolar lavage fluid (BALF) samples obtained from the right B6a bronchus. The serum sample obtained on the same day was positive on both PCR assay and sandwich ELISA test. Thus, the diagnosis of invasive pulmonary aspergillosis was established and intravenous amphotericin B commenced on August 7, 1997. However, renal dysfunc-PCRAssay for Pulmonary Aspergillosis therapy with amphotericin B. Another bronchoscopic examination was performed after one monthof treatment with itraconazole. BALFsamples were negative for A. fumigatus at that stage (Table 1) .
Discussion
In this report, we comparedthe usefulness of PCRassay for the early diagnosis of pulmonary aspergillosis with that by galactomannan detection tests. Pulmonary aspergillosis is a common opportunistic fungal infection in neutropenic patients, particularly after intensive chemotherapy or immunosuppressive therapy. Triazole antifungal agents are commonlyused as a prophylaxis against fungal infections in neutropenic patients. However, amphotericin B is considered the drug of choice for aspergillosis.
The most important factor related to the prognosis of pulmonary aspergillosis is the early use of amphotericin B at an appropriate dosage (4). Accordingly, an early confirmative diagnosis is essential for the commencement of treatment at an early stage. Mycological and histopathological examination under bronchofiberscopy was considered as the confirmative method for the diagnosis of pulmonary aspergillosis, but the use of bronchoscopy is potentially associated with some risk in the immunocompromizedpatient. Detection of the circulating galactomannan ofAspergillus spp. is currently used for the serodiagnosis of pulmonary aspergillosis.
Detection of galactomannan by latex agglutination test is widely used as a serodiagnostic test in clinical laboratories. However, this test may require at least 15 ng/ml of galactomannan in the serum sample for a positive result, suggesting a low sensitivity but high specificity. The new test for the detection of galactomannan based on the sandwich ELISAis reported to be very useful for the early diagnosis of invasive aspergillosis (5 Another strategy for the diagnosis of infectious diseases is the use of PCRamplification of the target DNA. In aspergillosis, the detection ofAspergillus DNAby PCR assay using serum samples was successful in the present case. Wecompared the usefulness of the PCRassay for the early diagnosis of aspergillosis with the serodiagnosis of sufficient concentrations of galactomannan using the same serum samples. While both tests were useful for the diagnosis of pulmonary aspergillosis, the PCRdetection of DNAofAspergillus was positive two days earlier than that of sandwich ELISA test of galactomannan. Sandwich ELISA was positive in only one sample obtained just before treatment with amphotericin B. Furthermore, the PCRbecamenegative after treatment with amphotericin B when BALFsamples became negative for A. fumigatus.
In conclusion, these results showed that based on the detection ofAspergillus DNA,PCRassay may be the most useful test for the early diagnosis of pulmonary aspergillosis.
